Skip to main content
NewslettersWatchlist

Teleflex Inc(TFX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low207.51
Day High211.97
Open:208.31
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Rally as AI Demand Fuels Record Earnings for Nvidia
Barchart
S&P Posts Record High as Nvidia Pushes Tech Stocks Higher
Barchart
Stocks Rally on Nvidia’s Blowout Earnings
Barchart
Stocks Pressured by Hawkish Fed But Close Mostly Higher
Barchart
Stocks Move Lower After Fed Meeting
Business Wire
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated
Barchart
Stocks Rally on Expectations for a Dovish U.S. CPI Report
Barchart
Stocks Climb on Hopes for U.S. Consumer Prices to Soften
Globe Newswire
Teleflex awarded Central Venous Access contract from Vizient
Globe Newswire
Teleflex Publishes 2021 Global Impact Report
Globe Newswire
Teleflex Announces Quarterly Dividend
Globe Newswire
Teleflex Reports Second Quarter Financial Results And Full Year Outlook
Globe Newswire
Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings
Globe Newswire
Teleflex Announces Second Quarter 2022 Earnings Conference Call Information
Globe Newswire
New Data Reinforce Efficacy of the UroLift® System for the Treatment of Enlarged Prostate
Globe Newswire
Teleflex Announces First Patient Enrollment in MANTA Ultra Study
Globe Newswire
Teleflex launches new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand
Globe Newswire
Teleflex launches new Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa region
Globe Newswire
Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program
Globe Newswire
Teleflex Hosts 2022 Analyst & Investor Day
Globe Newswire
Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)
Globe Newswire
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
Globe Newswire
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
Globe Newswire
Teleflex to Host Analyst & Investor Day on May 20, 2022
Globe Newswire
Teleflex Announces Quarterly Dividend
Globe Newswire
Teleflex Reports First Quarter Financial Results And Full Year Outlook
Globe Newswire
Teleflex Named to Forbes Best Employers for Diversity 2022 List
Globe Newswire
Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference
Globe Newswire
Teleflex Announces First Quarter 2022 Earnings Conference Call Information
Globe Newswire
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
Globe Newswire
Teleflex to Present at the KeyBanc Life Sciences & MedTech Investor Forum
Globe Newswire
Teleflex to Present at the 43rd Annual Raymond James Institutional Investors Conference

Profile

Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.